. In addition, many survivors of stroke remain significantly limited. In the setting of atrial fibrillation, the risk of stroke has been well studied and is increased by approximately 5-fold. The relationship between increasing age, increasing incidence of atrial fibrillation, and increasing incidence of stroke has also been well studied (3) (4) (5) . A variety of stroke risk scores have been developed to identify those at highest risk of stroke.
The most common currently used is the CHADS2-VASc score (6) . Such scores are used increasingly for patient education and decision making, and form an important part of professional guidelines. Such scores are particularly useful in identifying patients at very low risk of stroke as well as those at the other end of the spectrum.
In the past, anticoagulation with vitamin K antagonists (VKA) or novel factor Xa or direct thrombin inhibitors have been found to be effective for stroke prevention, reducing its incidence by approximately two-thirds, and have become the new standard of care (7) . However, although very effective, a substantial number of patients at risk for stroke are not treated because of increased risk of bleeding, previous bleeding episodes, patient frailty, inability to consistently follow medication recommendations, drug-drug interactions, patient discontinuation of drugs during follow-up, and managing physician uncertainties as to the required treatment for their patients (8) . In the highest-risk patients, including elderly patients, a substantial number, and in some practices even a majority of the elderly patients, are not treated. and along with Mayo Clinic, receives annual royalties >$10,000 from St. Jude Medical for mapping technology. holmes.david@mayo.edu.
